Induction of T-cell memory by a dendritic cell vaccine: A computational model

Bioinformatics

Volumn 30, Issue 13, 2014, Pages 1884-1891

  Pappalardo, Francesco ^a   Pennisi, Marzio ^a   Ricupito, Alessia ^b   Topputo, Francesco ^c   Bellone, Matteo ^d  

^a UNIVERSITY OF CATANIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c POLITECNICO DI MILANO   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CANCER VACCINE; VACCINE;

ANIMAL; C57BL MOUSE; DENDRITIC CELL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS; CANCER VACCINES; DENDRITIC CELLS; IMMUNOLOGIC MEMORY; MICE, INBRED C57BL; T-LYMPHOCYTES; VACCINES;

EID: 84903737191     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu059     Document Type: Article

References (48)

1. Banchereau, J. and Steinman, R. (1998) Dendritic cells and the control of immunity. Nature, 392, 245-252. (Pubitemid 28155090
2. Camporeale, A. et al. (2003) Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes. Cancer Res., 63, 3688-3694. (Pubitemid 36793053
3. Castiglione, F. et al. (2012) A modeling framework for immune-related diseases. Math. Model. Nat. Phenom., 7, 40-48
4. Chang, J. et al. (2007) Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science, 315, 1687-1691. (Pubitemid 46515618
5. DeBoer, R. et al. (2003) Different dynamics of CD4 and CD8 T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol., 171, 3929-3935
6. Finn, O. (2008) Cancer immunology. N. Engl. J. Med., 358, 2704-2715
7. Fridman, W. et al. (2012) The immune contexture in human tumours: Impact on clinical outcome. Nat. Rev. Cancer, 12, 298-306
8. Germain, R.N. et al. (2011) Systems biology in immunology: A computational modeling perspective. Annu. Rev. Immunol., 29, 527-585
9. Guarda, G. et al. (2007) L-selectin-negative CCR7- effector and memory CD8 T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol., 8, 743-752
10. Halling-Brown, M. et al. (2010) Immunogrid: Towards agent-based simulations of the human immune system at a natural scale. Philos. Trans. A Math. Phys. Eng. Sci., 368, 2799-2815
11. Jouanneau, E. et al. (2006) Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model. Cancer Immunol. Immunother., 55, 254-267
12. Kaech, S. et al. (2002) Effector and memory T-cell differentiation: Implications for vaccine development. Nat. Rev. Immunol., 2, 251-262
13. Kahn, J. (2009) HPV vaccination for the prevention of cervical intraepithelial eoplasia. N. Engl. J. Med., 361, 271-278
14. Kantoff, P. (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med., 363, 411-422
15. Kaufmann, S. (2010) Future vaccination strategies against tuberculosis: Thinking outside the box. Immunity, 33, 567-577
16. Kenter, G. et al. (2009) Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N. Engl. J. Med., 361, 1838-1847
17. Lollini, P. et al. (2011) Vaccines and other immunological approaches for cancer immunoprevention. Curr. Drug Targets, 13, 1957-1973
18. Lundegaard, C. et al. (2007) Modeling the adaptive immune system: Predictions and simulations. Bioinformatics, 23, 3265-3275. (Pubitemid 350238877
19. Marino, S. et al. (2008) A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol., 254, 178-196
20. Masopust, D. et al. (2006) Stimulation history dictates memory CD8 T cell phenotype: Implications for prime-boost vaccination. J. Immunol., 177, 831-839. (Pubitemid 44036583
21. Mckay, M. et al. (1979) Comparison of 3 methods for selecting values of input variables in the analysis of output from a computer code. Technometrics, 21, 239-245
22. Merad, M. and Manz, M. (2009) Dendritic cell homeostasis. Blood, 113, 3418-3427
23. Mestas, J. and Hughes, C. (2004) Of mice and not men: Differences between mouse and human immunology. J. Immunol., 172, 2731-2738. (Pubitemid 38263654
24. Mylin, L. et al. (1995) Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen. Virology, 208, 159-172
25. Overwijk, W. and Restifo, N. (2001) Creating therapeutic cancer vaccines: Notes from the battlefield. Trends Immunol., 22, 5-7. (Pubitemid 32675267
26. Palladini, A. et al. (2010) In silico modeling and in vivo efficacy of cancer-preventive vaccinations. Cancer Res., 70, 7755-7763
27. Pappalardo, F. et al. (2006) Genetic algorithm against cancer. Lect. Notes Comput. Sci., 3849, 223-228
28. Pappalardo, F. et al. (2009a) Agent based modeling of atherosclerosis: A concrete help in personalized treatments. Lect. Notes Comput. Sci., 5755, 386-396
29. Pappalardo, F. et al. (2009b) ImmunoGrid, an integrative environment for largescale simulation of the immune system for vaccine discovery, design and optimization. Brief. Bioinform., 10, 330-340
30. Pappalardo, F. et al. (2010) Vaccine protocols optimization: In silico experiences. Biotechnol. Adv., 28, 82-93
31. Pappalardo, F. et al. (2011) SimB16: Modeling induced immune system response against B16-melanoma. PLoS One, 6, e26523
32. Pappalardo, F. et al. (2012) Mathematical and computational models in tumor immunology. Math.Model. Nat. Phenom., 7, 186-203
33. Pennisi, M. et al. (2008) Optimal vaccination schedules using simulated annealing. Bioinformatics, 24, 1740-1742
34. Pennisi, M. et al. (2009) Searching of optimal vaccination schedules: Application of genetic algorithms to approach the problem in cancer immunoprevention. IEEE Eng. Med. Biol. Mag., 28, 67-72
35. Pennisi, M. et al. (2010) Modeling the competition between lung metastases and the immune system using agents. BMC Bioinformatics, 11 (Suppl. 7), S13
36. Perelson, A.S. and Weisbuch, G. (1997) Immunology for physicists. Rev. Mod. Phys., 69, 1219-1267
37. Ricupito, A. et al. (2013a) Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings. Cancer Res., 73, 3545-3554
38. Ricupito, A. et al. (2013b) Boosting anticancer vaccines: Too much of a good thing?. Oncoimmunology, 2, e25032
39. Rigamonti, N. et al. (2011) Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer. Clin. Cancer Res., 17, 1012-1023
40. Sallusto, F. et al. (2010) From vaccines to memory and back. Immunity, 33, 451-463
41. Saltelli, A (2004) Sensitivity Analysis in Practice: A Guide to Assessing Scientific Models. Wiley, Hoboken, NJ.
42. Schoenfeld, J. et al. (2010) Active immunotherapy induces antibody responses that target tumor angiogenesis. Cancer Res., 70, 10150-60
43. Sprent, J. and Surh, C. (2011) Normal T cell homeostasis: The conversion of naive cells into memory-phenotype cells. Nat. Immunol., 12, 478-484
44. Wherry, E. (2011) T cell exhaustion. Nat. Immunol., 12, 492-496
45. Wirth, T. et al. (2010) Modulating numbers and phenotype of CD8 T cells in secondary immune responses. Eur. J. Immunol., 40, 1916-1926
46. Yang, J. et al. (2006) Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8 T cells in vivo. Proc. Natl Acad. Sci. USA, 103, 147-152. (Pubitemid 43076119
47. Yewdall, A. et al. (2010) CD8 T Cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells. PLoS One, 5, e11144
48. Zinkernagel, R. (2002) On Differences between immunity and immunological memory. Curr. Opin. Immunol., 14, 523-536.